Star Combo Pharma Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was AUD 22.88 million compared to AUD 26.72 million a year ago. Net loss was AUD 0.696349 million compared to AUD 7.88 million a year ago.

Basic loss per share from continuing operations was AUD 0.005 compared to AUD 0.058 a year ago. Diluted loss per share from continuing operations was AUD 0.005 compared to AUD 0.058 a year ago.